vs
Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $138.0M, roughly 1.5× COASTAL FINANCIAL CORP). On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $122.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -3.6%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
CCB vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $205.4M |
| Net Profit | — | $17.0M |
| Gross Margin | — | 62.5% |
| Operating Margin | 12.4% | 29.6% |
| Net Margin | — | 8.3% |
| Revenue YoY | -5.8% | 12.9% |
| Net Profit YoY | — | 35.3% |
| EPS (diluted) | $0.84 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $205.4M | ||
| Q3 25 | $144.7M | $209.4M | ||
| Q2 25 | $119.4M | $188.0M | ||
| Q1 25 | $139.5M | $177.8M | ||
| Q4 24 | $146.5M | $181.9M | ||
| Q3 24 | $151.1M | $159.3M | ||
| Q2 24 | $135.3M | $145.3M | ||
| Q1 24 | $148.4M | $144.9M |
| Q4 25 | — | $17.0M | ||
| Q3 25 | $13.6M | $31.5M | ||
| Q2 25 | $11.0M | $12.0M | ||
| Q1 25 | $9.7M | $2.4M | ||
| Q4 24 | — | $12.5M | ||
| Q3 24 | $13.5M | $9.3M | ||
| Q2 24 | $11.6M | $19.6M | ||
| Q1 24 | $6.8M | $27.7M |
| Q4 25 | — | 62.5% | ||
| Q3 25 | — | 61.7% | ||
| Q2 25 | — | 57.7% | ||
| Q1 25 | — | 54.8% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 60.8% | ||
| Q2 24 | — | 62.5% | ||
| Q1 24 | — | 63.1% |
| Q4 25 | 12.4% | 29.6% | ||
| Q3 25 | 12.4% | 29.7% | ||
| Q2 25 | 12.0% | 18.7% | ||
| Q1 25 | 8.4% | 12.2% | ||
| Q4 24 | 11.7% | 20.9% | ||
| Q3 24 | 10.8% | 21.9% | ||
| Q2 24 | 11.1% | 32.7% | ||
| Q1 24 | 5.9% | 34.1% |
| Q4 25 | — | 8.3% | ||
| Q3 25 | 9.4% | 15.0% | ||
| Q2 25 | 9.2% | 6.4% | ||
| Q1 25 | 7.0% | 1.4% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | 8.9% | 5.9% | ||
| Q2 24 | 8.6% | 13.5% | ||
| Q1 24 | 4.6% | 19.1% |
| Q4 25 | $0.84 | $0.48 | ||
| Q3 25 | $0.88 | $0.84 | ||
| Q2 25 | $0.71 | $0.34 | ||
| Q1 25 | $0.63 | $0.07 | ||
| Q4 24 | $0.95 | $0.36 | ||
| Q3 24 | $0.97 | $0.27 | ||
| Q2 24 | $0.84 | $0.52 | ||
| Q1 24 | $0.50 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $386.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $491.0M | $301.7M |
| Total Assets | $4.7B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $386.7M | ||
| Q3 25 | — | $285.9M | ||
| Q2 25 | — | $222.2M | ||
| Q1 25 | — | $197.8M | ||
| Q4 24 | — | $162.8M | ||
| Q3 24 | — | $120.0M | ||
| Q2 24 | — | $271.6M | ||
| Q1 24 | — | $318.0M |
| Q4 25 | $491.0M | $301.7M | ||
| Q3 25 | $475.3M | $274.8M | ||
| Q2 25 | $461.7M | $232.2M | ||
| Q1 25 | $449.9M | $234.4M | ||
| Q4 24 | $438.7M | $228.8M | ||
| Q3 24 | $331.9M | $234.3M | ||
| Q2 24 | $316.7M | $216.6M | ||
| Q1 24 | $303.7M | $222.2M |
| Q4 25 | $4.7B | $1.7B | ||
| Q3 25 | $4.6B | $1.6B | ||
| Q2 25 | $4.5B | $1.6B | ||
| Q1 25 | $4.3B | $1.6B | ||
| Q4 24 | $4.1B | $1.7B | ||
| Q3 24 | $4.1B | $1.6B | ||
| Q2 24 | $4.0B | $1.1B | ||
| Q1 24 | $3.9B | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $254.6M | $123.0M |
| Free Cash FlowOCF − Capex | $246.1M | $122.4M |
| FCF MarginFCF / Revenue | 178.3% | 59.6% |
| Capex IntensityCapex / Revenue | 6.1% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $436.4M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $254.6M | $123.0M | ||
| Q3 25 | $59.0M | $78.4M | ||
| Q2 25 | $66.0M | $72.4M | ||
| Q1 25 | $71.7M | $55.4M | ||
| Q4 24 | $259.8M | $84.6M | ||
| Q3 24 | $62.6M | $-9.0M | ||
| Q2 24 | $72.1M | $67.4M | ||
| Q1 24 | $56.8M | $61.9M |
| Q4 25 | $246.1M | $122.4M | ||
| Q3 25 | $57.4M | $78.3M | ||
| Q2 25 | $64.0M | $72.4M | ||
| Q1 25 | $68.9M | $54.6M | ||
| Q4 24 | $249.9M | $84.1M | ||
| Q3 24 | $60.2M | $-9.2M | ||
| Q2 24 | $69.5M | $67.1M | ||
| Q1 24 | $55.0M | $61.4M |
| Q4 25 | 178.3% | 59.6% | ||
| Q3 25 | 39.7% | 37.4% | ||
| Q2 25 | 53.6% | 38.5% | ||
| Q1 25 | 49.4% | 30.7% | ||
| Q4 24 | 170.6% | 46.2% | ||
| Q3 24 | 39.8% | -5.8% | ||
| Q2 24 | 51.3% | 46.2% | ||
| Q1 24 | 37.1% | 42.3% |
| Q4 25 | 6.1% | 0.3% | ||
| Q3 25 | 1.2% | 0.1% | ||
| Q2 25 | 1.7% | 0.0% | ||
| Q1 25 | 2.0% | 0.4% | ||
| Q4 24 | 6.8% | 0.3% | ||
| Q3 24 | 1.6% | 0.2% | ||
| Q2 24 | 1.9% | 0.2% | ||
| Q1 24 | 1.2% | 0.4% |
| Q4 25 | — | 7.25× | ||
| Q3 25 | 4.34× | 2.49× | ||
| Q2 25 | 5.99× | 6.05× | ||
| Q1 25 | 7.37× | 22.92× | ||
| Q4 24 | — | 6.75× | ||
| Q3 24 | 4.65× | -0.96× | ||
| Q2 24 | 6.22× | 3.44× | ||
| Q1 24 | 8.35× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
COLL
Segment breakdown not available.
